Author

B. E. Gewurz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

B. Mitra· 2 shared S. P. T. Yiu· 2 shared A. K. Shalek· 1 shared A. Y. Huang· 1 shared B. Zhang· 1 shared B. Zhao· 1 shared B. Zhu· 1 shared C. M. Schurch· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. Mitra

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Epstein-Barr Virus BALF0/1 Subverts the Caveolin and ERAD Pathways to Target B-cell Receptor Complexes for Degradation

S. P. T. Yiu, M. P. Weekes, B. E. Gewurz

This paper identifies that EBV's BALF0/1 protein degrades B-cell receptor complexes by subverting caveolin and ERAD pathways, enhancing viral secretion.

Proceedings of the National Academy of Sciences · Jan 23, 2025Peer-reviewedMicrobiology

Epstein-Barr Virus Orchestrates Spatial Reorganization and Immunomodulation within the Classic Hodgkin Lymphoma Tumor Microenvironment

Y. Y. Yeo, H. Qiu, Y. Bai, B. Zhu, Y. Chang, J. Yeung, H. A. Michel, K. T. Wright, M. Shaban, S. Sadigh, D. Nkosi, V. Shanmugam, S. P. T. Yiu, P. Cramer, P. Rock, , S. Jiang

This study uses spatial multi-omics to compare EBV-positive and EBV-negative cHL, identifying distinct TME features and immunological signatures linked to EBV.

bioRxiv · Mar 5, 2024Cancer Biology

Characterization of Target Gene Regulation by the Two Epstein-Barr Virus Oncogene LMP1 Domains Essential for B-cell Transformation

B. Mitra, N. R. Beri, R. Guo, E. Burton, L. A. Murray-Nerger, B. E. Gewurz

This study identifies TES1 as critical for LCL survival and characterizes its gene regulatory effects compared to TES2.

bioRxiv · Apr 10, 2023Cancer Biology

Epstein-Barr virus latency programs dynamically sensitize B-cells to ferroptosis

E. M. Burton, J. Voyer, B. E. Gewurz

This study shows EBV-infected B-cells are sensitive to ferroptosis early in infection but become resistant later due to latency programs and lipid metabolism changes.

bioRxiv · Feb 21, 2022Microbiology